Disseminated Cryptococcus neoformans var. grubii infections in intensive care units

Epidemiology and Infection

Volumn 138, Issue 7, 2010, Pages 1036-1043

  Chuang, Y M ^a   Ku, S C ^a   Liaw, S J ^b   Wu, S C ^a   Ho, Y C ^a   Yu, C J ^a   Hsueh, P R ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cryptococcus neoformans var. grubii; Diabetes mellitus; HIV infection; Intensive care units; Liver cirrhosis; Prognosis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT;

ADULT; AGED; AIRWAY; ARTICLE; BLOODSTREAM INFECTION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DIABETES MELLITUS; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LONG TERM CARE; MALE; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

ASCITES; CROSS INFECTION; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DIABETES COMPLICATIONS; FEMALE; HEART DISEASES; HIV INFECTIONS; HUMANS; HYPERTENSION; INTENSIVE CARE UNITS; KIDNEY DISEASES; LIVER CIRRHOSIS; LUNG DISEASES; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES;

EID: 77953567621     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809990926     Document Type: Article

References (28)

1. Banerjee SN, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. American Journal of Medicine 1991; 91: 86S-89S.
2. Edmond MB, et al. Nosocomial bloodstream infections in United States hospitals : a three-year analysis. Clinical Infectious Diseases 1999; 29: 239-244.
3. Silva V, Diaz MC, Febre N. Invasive fungal infections in Chile : a multicenter study of fungal prevalence and susceptibility during a 1-year period. Medical Mycology 2004; 42: 333-339.
4. Petri MG, et al. Epidemiology of invasive mycosis in ICU patients : a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Medicine 1997; 23: 317-325.
5. Singh N, et al. Bloodstream infections in liver transplant recipients receiving tacrolimus. Clinical Transplantation 1997; 11: 275-281.
6. Patterson JE. Epidemiology of fungal infections in solid organ transplant patients. Transplant Infectious Diseases 1999; 1: 229-236.
7. Khasawneh F, et al. Isolation of Aspergillus in critically ill patients : a potential marker of poor outcome. Journal of Critical Care 2006; 21: 322-327.
8. Vandewoude KH, et al. Invasive aspergillosis in critically ill patients : attributable mortality and excesses in length of ICU stay and ventilator dependence. Journal of Hospital Infection 2004; 56: 269-276.
9. Dimopoulos G, et al. Candidemia in immunocompromised and immunocompetent critically ill patients : a prospective comparative study. European Journal of Clinical Microbiology & Infectious Diseases 2007; 26: 377-384.
10. Singh N, et al. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clinical Infectious Diseases 1997; 24: 179-184. (Pubitemid 27081540)
11. Pappas PG, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clinical Infectious Diseases 2001; 33: 690-699.
12. Rabkin JM, et al. Association of fungal infection and increased mortality in liver transplant recipients. American Journal of Surgery 2000; 179: 426-430.
13. Vilchez RA, et al. The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center. Medicine (Baltimore) 2001; 80: 308-312.
14. Jean SS, et al. Cryptococcaemia: clinical features and prognostic factors. Quarterly Journal of Medicine 2002; 95: 511-518.
15. Perfect JR. Cryptococcosis. Infectious Disease Clinics of North America 1989; 3: 77-102.
16. Jongwutiwes U, Sungkanuparph S, Kiertiburanakul S. Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients. Japanese Journal of Infectious Diseases 2008; 61: 111-115.
17. Darras-Joly C, et al. Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus. Clinical Infectious Diseases 1996; 23: 369-376.
18. Hazen KC, Howell SA. Candida, Cryptococcus, and other yeasts of medical importance. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of Clinical Microbiology, 9th edn. Washington, DC: American Society for Microbiology, 2007, pp. 1762-1788.
19. Meyer W, et al. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerging Infectious Diseases 2003; 9: 189-195.
20. Chuang YM, et al. Disseminated cryptococcosis in HIV-uninfected patients. European Journal of Clinical Microbiology & Infectious Diseases 2008; 27: 307-310.
21. Franca AV, et al. Cryptococcosis in cirrhotic patients. Mycoses 2005; 48: 68-72.
22. Saag MS, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clinical Infectious Diseases 2000; 30: 710-718.
23. Yamaguchi H, et al. Fluconazole monotherapy for cryptococcosis in non-AIDS patients. European Journal of Clinical Microbiology & Infectious Diseases 1996; 15: 787-792.
24. Kokturk N, et al. Disseminated cryptococcosis in a human immunodeficiency virus-negative patient : a case report. Mycoses 2005; 48: 270-274.
25. Zhu LP, Gil-Lamaignere C, Muller FM. Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China. Mycoses 2004; 47: 319-325.
26. Ruan SY, et al. Candida glabrata fungaemia in intensive care units. Clinical Microbiology and Infection 2008; 14: 136-140.
27. Perfect JR, Durack DT, Gallis HA. Cryptococcemia. Medicine (Baltimore) 1983; 62: 98-109.
28. Casalino E, et al. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 2004; 18: 1429-1433.